Phil Lieberman

Summary

Publications

  1. doi request reprint Recognition and first-line treatment of anaphylaxis
    Phillip L Lieberman
    University of Tennessee College of Medicine, Germantown, Tenn Electronic address
    Am J Med 127:S6-11. 2014
  2. doi request reprint Nonallergic Rhinitis: Treatment
    Phillip L Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, Memphis, TN, USA Department of Pediatrics, University of Tennessee, Memphis, TN, USA Electronic address
    Immunol Allergy Clin North Am 36:305-19. 2016
  3. pmc The risk and management of anaphylaxis in the setting of immunotherapy
    Phil Lieberman
    Allergy and Asthma Care, Germantown, Tennessee 38138, USA
    Am J Rhinol Allergy 26:469-74. 2012
  4. doi request reprint Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis
    Phil Lieberman
    Allergy and Asthma Care, Germantown, Tennessee 38138, USA
    Allergy Asthma Proc 32:151-8. 2011
  5. doi request reprint The diagnosis and management of anaphylaxis practice parameter: 2010 update
    Phillip Lieberman
    JointCouncil of Allergy, Asthma and Immunology, 50NBrockway St, 3 3, Palatine, IL 60067, USA
    J Allergy Clin Immunol 126:477-80.e1-42. 2010
  6. ncbi request reprint Anaphylaxis: a review of 601 cases
    Luke M Webb
    Department of Internal Medicine, University of Tennessee, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 97:39-43. 2006
  7. doi request reprint Epidemiology of anaphylaxis
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, College of Medicine, Memphis, Tennessee, USA
    Curr Opin Allergy Clin Immunol 8:316-20. 2008
  8. ncbi request reprint Use of epinephrine in the treatment of anaphylaxis
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, Memphis, Cordova, Tennessee 38018, USA
    Curr Opin Allergy Clin Immunol 3:313-8. 2003
  9. ncbi request reprint The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen
    Mathew Varghese
    University of Tennessee, Health Science Center, 930 Madison Avenue, Memphis, TN 38163, USA
    Allergy Asthma Proc 28:320-3. 2007
  10. ncbi request reprint Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group
    Phil Lieberman
    Division of Allergy Immunology, Department of Medicine, University of Tennessee College of Medicine, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 97:596-602. 2006

Detail Information

Publications21

  1. doi request reprint Recognition and first-line treatment of anaphylaxis
    Phillip L Lieberman
    University of Tennessee College of Medicine, Germantown, Tenn Electronic address
    Am J Med 127:S6-11. 2014
    ..Patients should have ready access to >1 epinephrine autoinjector in the outpatient setting. An individualized emergency action plan should be developed for each patient at risk for anaphylaxis. ..
  2. doi request reprint Nonallergic Rhinitis: Treatment
    Phillip L Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, Memphis, TN, USA Department of Pediatrics, University of Tennessee, Memphis, TN, USA Electronic address
    Immunol Allergy Clin North Am 36:305-19. 2016
    ..In general the most effective therapy is the combination of an intranasal antihistamine and an intranasal corticosteroid. ..
  3. pmc The risk and management of anaphylaxis in the setting of immunotherapy
    Phil Lieberman
    Allergy and Asthma Care, Germantown, Tennessee 38138, USA
    Am J Rhinol Allergy 26:469-74. 2012
    ..Anaphylactic events due to immunotherapy are probably not completely preventable. There is always an inherent risk surrounding the administration of an allergen to an individual who is sensitized to the substance administered...
  4. doi request reprint Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis
    Phil Lieberman
    Allergy and Asthma Care, Germantown, Tennessee 38138, USA
    Allergy Asthma Proc 32:151-8. 2011
    ..OLO has a similar efficacy and safety profile to AZE for the management of VMR in patients ≥12 years of age...
  5. doi request reprint The diagnosis and management of anaphylaxis practice parameter: 2010 update
    Phillip Lieberman
    JointCouncil of Allergy, Asthma and Immunology, 50NBrockway St, 3 3, Palatine, IL 60067, USA
    J Allergy Clin Immunol 126:477-80.e1-42. 2010
    ..These parameters are not designed for use by pharmaceutical companies in drug promotion...
  6. ncbi request reprint Anaphylaxis: a review of 601 cases
    Luke M Webb
    Department of Internal Medicine, University of Tennessee, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 97:39-43. 2006
    ..Knowledge of the characteristics of such patients is essential to achieve these goals...
  7. doi request reprint Epidemiology of anaphylaxis
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, College of Medicine, Memphis, Tennessee, USA
    Curr Opin Allergy Clin Immunol 8:316-20. 2008
    ..This, in turn, has a bearing on efforts related to prevention and management...
  8. ncbi request reprint Use of epinephrine in the treatment of anaphylaxis
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, Memphis, Cordova, Tennessee 38018, USA
    Curr Opin Allergy Clin Immunol 3:313-8. 2003
    ..This paper is intended to review recent literature that impacts the use of epinephrine in the therapy of anaphylaxis...
  9. ncbi request reprint The effects of repeat omalizumab administration on skin test positivity and the assessment of the safety of administration in patients with positive skin tests to mouse antigen
    Mathew Varghese
    University of Tennessee, Health Science Center, 930 Madison Avenue, Memphis, TN 38163, USA
    Allergy Asthma Proc 28:320-3. 2007
    ..Furthermore, a positive skin test to mouse antigen does not automatically preclude the use of omalizumab for therapy of moderate-to-severe allergic asthma...
  10. ncbi request reprint Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group
    Phil Lieberman
    Division of Allergy Immunology, Department of Medicine, University of Tennessee College of Medicine, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 97:596-602. 2006
    ..To improve understanding of the epidemiology of anaphylaxis...
  11. ncbi request reprint Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology
    Leonard Bielory
    Department of Medicine, UMDNJ New Jersey Medical School, Newark, USA
    Ann Allergy Asthma Immunol 96:514-25. 2006
    ..Thus, as stated, we recommend that intranasal corticosteroids remain prescription-only drugs...
  12. doi request reprint Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologist
    Debendra Pattanaik
    Department of Medicine, Division of Allergy and Immunology, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN, USA
    Future Cardiol 8:555-62. 2012
    ..This article highlights the importance of aspirin desensitization, the mechanism and the process involved. We draw attention to recently described rapid desensitization protocols and how they can be more useful than the old procedure...
  13. ncbi request reprint The unusual suspects: a surprise regarding reactions to omalizumab
    Phil Lieberman
    Division of Allergy and Immunology, University of Tennessee, Memphis, Tennessee, USA
    Allergy Asthma Proc 28:259-61. 2007
  14. ncbi request reprint Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations
    John W Tole
    Department of Internal Medicine, University of Tennessee Health Science Center, 842 Jefferson Avenue, Suite A601, Memphis, TN 38103, USA
    Immunol Allergy Clin North Am 27:309-26, viii. 2007
    ....
  15. doi request reprint Nonallergic rhinitis
    Phil Lieberman
    Clinical Professor of Medicine and Pediatrics, University of Tennessee College of Medicine, Allergy and Asthma Care, 7205 Wolf River Blvd, Suite 200, Germantown, TN, 38138, USA
    Curr Allergy Asthma Rep 14:439. 2014
    ..This review will concentrate on chronic nonallergic rhinitis in its various forms, discussing the epidemiology, underlying mechanisms, and its therapy. ..
  16. ncbi request reprint Anaphylactic reactions during surgical and medical procedures
    Phil Lieberman
    Division of Allergy and Immunology, Departments of Medicine and Pediatrics, University of Tennessee, Memphis, TN 38018, USA
    J Allergy Clin Immunol 110:S64-9. 2002
    ..This is particularly important in the operating and recovery rooms...
  17. ncbi request reprint Objective measures of asthma control: sputum eosinophils, nitric oxide, and other inflammatory mediators
    Phil Lieberman
    Division of Allergy and Immunology, Department of Medicine, University of Tennessee, College of Medicine, Memphis, TN, USA
    Allergy Asthma Proc 28:510-3. 2007
    ..Therefore, tools to measure the status of inflammation would be extremely helpful. In this article two such tools are discussed: the measurement of eosinophilia and the assessment of exhaled nitric oxide...
  18. pmc Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel
    Joshua A Boyce
    Division of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Department of Medicine, Harvard Medical School, Boston, MA, USA
    J Allergy Clin Immunol 126:S1-58. 2010
    ..They also identify gaps in the current scientific knowledge to be addressed through future research...
  19. ncbi request reprint Biphasic anaphylactic reactions
    Phil Lieberman
    Department of Medicine and Pediatrics, University of Tennessee College of Medicine, Germantown, Tennessee, USA
    Ann Allergy Asthma Immunol 95:217-26; quiz 226, 258. 2005
    ..To examine the impact of the second phase of a biphasic response on the required observation time after resolution of symptoms that occurred during the initial phase...
  20. ncbi request reprint Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis
    Phil Lieberman
    Allergy and Asthma Care, Germantown, TN, USA
    Curr Med Res Opin 21:611-8. 2005
    ....